COMPANY PROFILE · UPDATED 01 AUG 2026

Ginkgo Bioworks

Ginkgo Bioworks is a biotech company from the United States founded in 2009 by scientists from MIT and headed by Tom Knight. The company specializes in using genetic engineering to produce bacteria with industrial applications. Ginkgo…

www.ginkgobioworks.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2008
Headcount: 780
Open roles: 17
Last raised: IPO · Sign in to view

TECH STACK

How Ginkgo Bioworks builds

Extracted from Ginkgo Bioworks’s job postings we’ve tracked

Other Software & Platforms

Foundry×21 reStructuredText×4 Shopify×2

DevOps & Infrastructure

Docker/Kubernetes×3 Kubernetes×3 Windows×3 Git×2 GitHub×2

Programming Languages

Python×8 TypeScript×3

Cloud Platforms

Amazon Web Services×3 Google Cloud×2 Microsoft Azure×2

CRM & Sales Tools

HubSpot×3 Salesforce×2

Data Engineering & Warehousing

Apache Kafka×2

Analytics & BI

Google Analytics×2

AI & Machine Learning

LangChain×2

Databases

PostgreSQL×2

Design Tools

SolidWorks×2

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Ginkgo Bioworks

View all 17 open roles →

FUNDING

Capital raised

Total raised

$1,575,403,063

Investors

Y Combinator11.2 CapitalARK Investment ManagementAllen & Company of FloridaArda KutsalArrowMark PartnersAzure Capital PartnersBaillie Gifford & CoBain Capital Public EquityBill GatesCascade InvestmentCasdin CapitalCounterpointDCVCDavid SpectorEmpede CapitalFarzad NazemFelicis VenturesFranklin AdvisorsGeneral AtlanticID Ventures AmericaIlluminaJonathan DowneyKen ArnoldKen ChengLouis BerylMEROSMassVenturesNational Science FoundationNorthern Star PartnersOS FundPutnam InvestmentsSenator Investment GroupT. Rowe PriceTSVCTodd CorensonVast VenturesViking Global Investorsbpd partnersiGlobe Partners

Funding rounds

IPO
UndisclosedJan 1, 2022
Post Ipo Equity
Northern Star Partners, Counterpoint, ARK Investment Management, T. Rowe Price, ArrowMark Partners, Casdin Capital, Franklin Advisors, Putnam Investments, Viking Global Investors, Cascade Investment, Bain Capital Public Equity, Baillie Gifford & Co
$775MSep 16, 2021
Series F
General Atlantic, Illumina, Viking Global Investors, Empede Capital
$70MMay 27, 2020
Series E
Viking Global Investors, Cascade Investment, General Atlantic, T. Rowe Price, MEROS
$290MSep 18, 2019
Series D
Bill Gates, Cascade Investment, Viking Global Investors, Y Combinator, General Atlantic, bpd partners
$275MDec 13, 2017
Series C
Senator Investment Group, Cascade Investment, Baillie Gifford & Co, Viking Global Investors, Allen & Company of Florida, Y Combinator
$100MJun 7, 2016
Series B
Viking Global Investors, OS Fund, Felicis Ventures, 11.2 Capital, Vast Ventures, Ken Arnold, ID Ventures America, MassVentures, DCVC, iGlobe Partners, Y Combinator
$53.3MJul 22, 2015
Series A
Felicis Ventures, OS Fund, DCVC, iGlobe Partners, Vast Ventures
$9MMar 17, 2015
Grant
National Science Foundation
$180KDec 1, 2014
Seed
Y Combinator, TSVC, Farzad Nazem, David Spector, 11.2 Capital, Todd Corenson, Ken Cheng, Ken Arnold, Arda Kutsal, Louis Beryl, Jonathan Downey, Vast Ventures, Azure Capital Partners, Felicis Ventures
$1MJul 15, 2014
Grant
MassVentures
$400KDec 31, 2013
Grant
National Science Foundation
$1.3MApr 8, 2013
Grant
National Science Foundation
$180KDec 9, 2012

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Investors

Y Combinator

Industries

Software Companies Medical Organizations Biotechnology Companies

Tech Stack

Mysql Php Ruby On Rails Ruby Python React Amazon Web Services Next.js Typescript C++Scala Wordpress Java Nodejs

LOCATIONS

Where they work

Ginkgo Bioworks offices

Loading map…

Boston, MA27 Drydock Avenue 8th Floor
Emeryville, CA